Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Disease-modifying anti-rheumatic drugs for the management of Takayasu arteritis—a systematic review and meta-analysis

Clinical Rheumatology(2021)10.1007/s10067-021-05743-2Source: DataRank Database

Disease-modifying anti-rheumatic drugs for the management of Takayasu arteritis—a systematic review and meta-analysis is a research paper published in Clinical Rheumatology (2021). On theSindex it has a DataRank of 0. It has been cited 83 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access83 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 5.59)OA: bronzeTopics (32)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Upendra Rathore ORCID,Pallavi Patro ORCID,Vikas Agarwal ORCID,Aman Sharma ORCID,Durga Prasanna Misra ORCID

Live enrichment

PubMed:33932173 PMC:PMC8087890 OpenAlex:https://openalex.org/W3157270391

Indian Council of Medical Research

Grant: 5/4/1-2/2019-NCD-II

FWCI

5.59

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

bronzeLicense: https://www.springernature.com/gp/researchers/text-and-data-mining

journalhttps://link.springer.com/content/pdf/10.1007/s10067-021-05743-2.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s10067-021-05743-2.pdf

publisherhttps://link.springer.com/article/10.1007/s10067-021-05743-2/fulltext.html

journalhttps://doi.org/10.1007/s10067-021-05743-2

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33932173

Fields of Study

Vasculitis and related conditionsRenal Diseases and GlomerulopathiesSystemic Lupus Erythematosus ResearchAbataceptAntibodies, MonoclonalAntirheumatic AgentsHumansNeoplasm Recurrence, LocalRandomized Controlled Trials as TopicTakayasu Arteritis

MeSH Terms

AbataceptAntibodies, MonoclonalHumansNeoplasm Recurrence, LocalTakayasu ArteritisRandomized Controlled Trials as TopicAntirheumatic Agents

Keywords

MedicineObservational studyRandomized controlled trialInternal medicineTocilizumabRheumatologyPharmacotherapyPhysical therapyDiseaseMeta-analysisAnti-rheumatic DrugsTakayasu ArteritisBiological DrugsAortoarteritisDisease-modifying Systematic Review

Sustainable Development Goals

SDG 0: Good health and well-being

Disease-modifying anti-rheumatic drugs for the management of Takayasu arteritis—a systematic review and meta-analysis

FAIR Checklist

Authors (5)

Funding (1 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)